Archon Biosciences
About:
Archon is a biotechnology firm that promotes next-generation antibody treatments through AI and computational protein design.
Website: https://www.archon.bio/
Top Investors: Alexandria Venture Investments, Madrona, WRF Capital, Cornucopian Capital, DUMAC
Description:
Archon is a biotechnology firm that creates computationally engineered proteins to unleash potent therapeutic targets beyond the grasp of current methods and improve disease management.
Total Funding Amount:
$20M
Headquarters Location:
Washington, District of Columbia, United States
Founded Date:
Contact Email:
contact(AT)archon.bio
Founders:
George Ueda, James Lazarovits
Number of Employees:
11-50
Last Funding Date:
2024-10-30
IPO Status:
Private
Industries:
© 2025 bioDAO.ai